Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis.
- DOI
- 10.1186/s13063-020-04516-7
- Published
- 2020 Jul 8
- Container
- Trials
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13063-020-04516-7,
title = {Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis.},
author = {Wickel J and Chung HY and Platzer S and Lehmann T and Prüss H and Leypoldt F and Günther A and Scherag A and Geis C and GENERATE Study Group},
year = {2020},
journal = {Trials},
doi = {10.1186/s13063-020-04516-7},
url = {https://doi.org/10.1186/s13063-020-04516-7}
}RIS
TY - JOUR TI - Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis. AU - Wickel J AU - Chung HY AU - Platzer S AU - Lehmann T AU - Prüss H AU - Leypoldt F AU - Günther A AU - Scherag A AU - Geis C AU - GENERATE Study Group PY - 2020 JO - Trials DO - 10.1186/s13063-020-04516-7 UR - https://doi.org/10.1186/s13063-020-04516-7 ER -
APA
J, W., HY, C., S, P., T, L., H, P., F, L., A, G., A, S., C, G., & Group, G. S. (2020). Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis.. Trials. https://doi.org/10.1186/s13063-020-04516-7
Source records
- pubmed · retrieved 2026-09-26T22:40:21.100Z